Concepedia

Author

Kyriakos Revelos

Evangelismos HospitalORCID

Also Known As

K. Revelos, Kyriakos Revelos

19

Publications

285

Citations

10

H-Index

31

Concepts

All Affiliations

Evangelismos HospitalNational and Kapodistrian University of Athens
KR

About

Kyriakos Revelos is an author at Evangelismos Hospital specializing in medicine, pathology, and histopathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

87

2

Pathology

2

2

87

3

Engineering

1

1

46

4

Biostatistics

1

1

46

5

Data Science

1

1

46

Kyriakos Revelos

×

8

Publications

231

Citations

8

H-Index

YearCitations

Ensembling EfficientNets for the Classification and Interpretation of Histopathology Images

Athanasios Kallipolitis, Kyriakos Revelos, Ilias Maglogiannis

Algorithms

2021

46

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

Kyriakos Revelos, Constantina Petraki, Alkiviadis Gregorakis,

PubMed

2005

41

Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.

Kyriakos Revelos, Constantina Petraki, Andreas Scorilas,

PubMed

2007

39

Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy.

Kyriakos Revelos, Constantina Petraki, Alkiviadis Gregorakis,

PubMed

2005

38

Aggressive digital papillary adenoma-adenocarcinoma

Evangelos Keramidas, Gavin Miller, Kyriakos Revelos,

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

2006

24

Molecular analysis of NUT‐positive poromas and porocarcinomas identifies novel break points of <i>YAP1::NUTM1</i> fusions

Justin T. Snow, Natalia Georgantzoglou, Donald C. Green,

Journal of Cutaneous Pathology

2022

16

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Constantina Petraki, Michael Vaslamatzis, Kalliopi Petraki,

Scandinavian Journal of Urology and Nephrology

2005

15

Rationale for the Application of RANKL Inhibition in the Treatment of Langerhans Cell Histiocytosis

Polyzois Makras, Maria Salagianni, Kyriakos Revelos,

The Journal of Clinical Endocrinology & Metabolism

2014

12

Page 1